Nebracetam

Nebracetam
Clinical data
ATC code	none;
Legal status
Legal status	AU: S4 (Prescription only); US: Unscheduled Not FDA approved;
Identifiers
	IUPAC name (RS)-4-(Aminomethyl)-1-benzylpyrrolidin-2-one;
JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES O=C2N(Cc1ccccc1)CC(C2)CN;
	InChI InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 ; Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N ;
	(what is this?) (verify)

Nebracetam is an

chemoenzymatic method of synthesis was reported in 2008.^[4] As of 2023

, human trials have not yet been conducted.

References

PMID 9179389
.

PMID 2041225
.

PMID 11126618
.

ISSN 0957-4166
.

v
t
e
Racetams

Aniracetam

Brivaracetam

Cebaracetam

Coluracetam

Dimiracetam

Doliracetam

Dupracetam

Etiracetam/Levetiracetam

Fasoracetam

Imuracetam

Methylphenylpiracetam

Nebracetam

Nefiracetam

Omberacetam (Noopept)

Oxiracetam

Phenylpiracetam

Phenylpiracetam hydrazide

Piracetam

Pramiracetam

Rolipram

Rolziracetam

Seletracetam

drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
v
t
e

[1] PMID 9179389
.

[2] PMID 2041225
.

[3] PMID 11126618
.

[4] ISSN 0957-4166
.

[4]

See also

References